| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/04/2001 | EP0618810B1 Bradykinin antagonist peptides |
| 07/04/2001 | CN1302296A Novel 2-alkyl substituted imidazole compounds |
| 07/04/2001 | CN1302183A Xylitol compositions for treating upper respiratory conditions |
| 07/04/2001 | CN1301563A Medicine for curing rheumatoid arthritis and preparing method |
| 07/04/2001 | CN1301553A Capsule for calming the endopathic wind and eliminating febrile disease |
| 07/04/2001 | CN1301547A Analgesic plaster for osteoarthritis |
| 07/04/2001 | CN1301544A Medicinal composition for curing arthritis and osteoarthropathy and its preparing method |
| 07/04/2001 | CN1067989C New compound with analgesic and local anaesthetic effect |
| 07/04/2001 | CN1067986C 1H-indole-3-acetic acid hydrazide phospholipid enzyme A2 inhibitors |
| 07/03/2001 | USRE37263 Topically applying two solutions, gels or creams one of a metal chlorite and thickener and one of a protic acid and thickener |
| 07/03/2001 | US6255490 Treating disorders associated with changes in cholinergic activity; non-opiate based analgesic for moderate to severe pain equally or exceeding the potency of opiate analgesics, yet lacking addictive side effects |
| 07/03/2001 | US6255468 MPROT12 polynucleotides and methods thereof |
| 07/03/2001 | US6255353 Inhibition of angiogenesis |
| 07/03/2001 | US6255348 Use of aminoadamantane compounds as immunoregulators |
| 07/03/2001 | US6255281 Complexing uteroglobin to fibronectin |
| 07/03/2001 | US6255100 Cyclosporin fermentation process |
| 07/03/2001 | US6255046 Drug screening of enzyme inhibitors by expressing enzyme or kinase domain, purifying, isolating, adding test compound and fructose 6-phosphate, and measuring formation of fructose 2,6 bisphosphate product; reduction indicates candidate |
| 07/03/2001 | US6254887 Controlled release tramadol |
| 07/03/2001 | US6254853 Drugs with carriers |
| 06/30/2001 | CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them |
| 06/28/2001 | WO2001046475A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046394A2 Mammalian protein phosphatases |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046263A1 Novel compounds |
| 06/28/2001 | WO2001046258A2 Transporters and ion channels |
| 06/28/2001 | WO2001046256A2 Vesicle trafficking proteins |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046232A2 Soluble interleukin-20 receptor |
| 06/28/2001 | WO2001046218A2 Fragments of pf4 and pharmaceutical compositions containing the same |
| 06/28/2001 | WO2001046200A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | WO2001046194A2 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives |
| 06/28/2001 | WO2001046191A1 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives |
| 06/28/2001 | WO2001046184A1 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046183A1 SUBSTITUTED 1,3,4-OXADIAZOLES AND A METHOD OF REDUCING TNF-α LEVELS |
| 06/28/2001 | WO2001046180A2 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 06/28/2001 | WO2001046176A2 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | WO2001046174A1 Novel compounds |
| 06/28/2001 | WO2001046172A1 Pyrazole cyclic amp-specific pde inhibitors |
| 06/28/2001 | WO2001046171A1 Amidine derivatives which are inhibitors of nitric oxide synthase |
| 06/28/2001 | WO2001046168A1 Tryptase inhibitors |
| 06/28/2001 | WO2001046167A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 06/28/2001 | WO2001046136A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046128A2 Tryptase inhibitors |
| 06/28/2001 | WO2001045751A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | WO2001045749A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | WO2001045742A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 06/28/2001 | WO2001045725A2 Treatment for inflammatory bowel disease (ibd) and related conditions |
| 06/28/2001 | WO2001045723A1 Medicines manufactured from old platycodon extracts |
| 06/28/2001 | WO2001045715A2 Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain |
| 06/28/2001 | WO2001045714A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045713A1 Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method |
| 06/28/2001 | WO2001045706A1 Dual-release compositions of a cyclooxygenase-2- inhibitor |
| 06/28/2001 | WO2001045705A1 Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 06/28/2001 | WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | WO2001045702A1 SUBSTITUTED ACYLHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 06/28/2001 | WO2001045700A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045694A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045686A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045684A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045682A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045661A2 Cosmetic and/or pharmaceutical preparations |
| 06/28/2001 | WO2001045650A2 Cosmetic use of the residues from wine production |
| 06/28/2001 | WO2001045509A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/28/2001 | WO2001005974A9 The il-1l1 gene and polypeptide products |
| 06/28/2001 | WO2000078776A3 Thiophene a2a receptor agonists |
| 06/28/2001 | WO2000078322A3 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 06/28/2001 | WO2000075144A3 Peroxynitrite decomposition catalysts and methods of use thereof |
| 06/28/2001 | WO2000073344A3 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000068247A3 Serine proteases |
| 06/28/2001 | WO2000066104A3 Ace-2 inhibiting compounds and methods of use thereof |
| 06/28/2001 | WO2000061180A3 Products and methods for treating ptp lar related diseases |
| 06/28/2001 | WO1997046686A3 Tumor necrosis factor-related polypeptide |
| 06/28/2001 | US20010005729 Absorption rate of a pharmaceutically active amine such as pseudoephedrine is improved when formulated with an acidic nonsteroidal antiinflammatory drug such as ibuprofen in a liquid medium; includes dosage for children |
| 06/28/2001 | DE19962936A1 New beta-aminoacid amide derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological disorders e.g. asthma, diabetes or rheumatoid arthritis |
| 06/28/2001 | DE19960640A1 Neue Stromelysin Inhibitoren New stromelysin inhibitors |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | CA2399584A1 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | CA2395569A1 Process for the preparation of pyrazolo[1,5-b]pyridazine derivatives |
| 06/28/2001 | CA2395471A1 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives |
| 06/28/2001 | CA2395435A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | CA2395300A1 Novel compounds |
| 06/28/2001 | CA2395202A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | CA2395136A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | CA2395113A1 Pyrazole cyclic amp-specific pde inhibitors |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394864A1 Novel compounds |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2394604A1 Substituted acylhydroxamic acids and method of reducing tnf.alpha. levels |
| 06/28/2001 | CA2394603A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | CA2394222A1 Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 06/28/2001 | CA2394139A1 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 06/28/2001 | CA2394095A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2393855A1 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | CA2393724A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2392127A1 Tryptase inhibitors |